In the present study, we demonstrated that atorvastatin improves survival in septic rats, decreases circulating inflammatory cytokines and improves insulin resistance, in parallel with a decrease in TLR4 signaling and an improvement in insulin signaling in liver, muscle and adipose tissue. Here, INS is linked to Insulin resistance.